Market close: Ryman’s resurgence: Shares climb off 13-year low
The NZ sharemarket closed down 28.39 points or 0.23%.
AdvertisementAdvertise with NZME.
Latest from Healthcare
Asset values up only $100m since 2022: New report on 10 biggest iwi
Most iwi had positive financial returns in 2024, an improvement on 2023: latest report
F&P Healthcare starts vast new $250m building
Earthworks have been largely completed and construction will start later this month.
Kiwi food tech firm expands reach with major Australian aged care deal
The Pure Food Co will supply up to 50,000 meals monthly to Regis Aged Care.
‘Yoga impacted by construction noise’: Arvida’s $50m+ fix-up irks some
Arvida is spending $50m+ on the main hub and apartments at its Mayfair retirement village.
Horse medicine for humans? NZ breakthrough could revolutionise wound treatment
Gel could help diabetics, the elderly and burns patients heal a lot quicker.
Summerset may ban non-residents receiving care in its hospitals
Summerset has 28 villages with hospital and resthome-level care.
Ebos CEO Cullity resigns, first-half result solid
John Cullity will be replaced by Adam Hall.
Property Insider: Fixing Ryman’s sinking Edmund Hillary hub; Britomart revitalisation turning 20
Site was rubbish dump, says boss of Mainmark, drilling through floor slabs up to 4m down.
Why NZ needs more Māori nurses for culturally safe care
Māori nurses make up only 7% of the workforce, despite 17% of the population.
Dug down, walls now rising for $400m Mount Maunganui retirement village
A giant sandpile sits at the centre of the site where perimeter walls have been built.
One crucial word was missed from NZX announcement: Summerset CEO
A word can change a meaning and that was the case with the NZX statement on Tuesday.
Ten most valuable deals by foreigners trading NZ assets in latest year
Value of deals in 2024 was less than half the value of those the previous year.
Bruce Cotterill: Health system in crisis - the need for radical change
Why New Zealand’s health outcomes are declining despite funding boost.
Retirement village dispute: Race, gender prejudice cited, residents lost
Fight over weekly fees charged by the operator had morphed into something else: decision
Spotless NZ businesses sold in cleaning, catering shakeup
Clients include a major stadium and some of the country's most prestigious schools.
Fisher & Paykel Healthcare says new products boost profit
F&P Healthcare lifts first-half profit as hospitals returned to more normalised staffing.
Medicinal cannabis grower Puro seals Australian deal
The company is highlighting the regulatory roadblocks that prevent distribution here.
The Kiwi millionaire couple giving wealth away
'The more you give, the more will come back to you,' says Ranjna Patel.
The company that had its share price jump 900% in a year
How one company achieved the best performance – then lost all its gains.
Fran O'Sullivan: Are Govt appointments a poisoned chalice for directors?
OPINION: Is taking on a Government appointment worth the risk?
'Back off Arvida' - union protest against cuts at village owned by $4.2b retirement giant
'Won’t be able to care for all of them because there won’t be enough time.'
How two developers gazumped Government plans for Auckland's housing 'flood'
Developers have fought for years to create new townships on outskirts of Auckland.
A royal compromise: Why Covid inquiry chair is leaving
Government reveals an inelegant solution to an untenable Covid inquiry problem.
F&P Healthcare shares climb as revenue jumps 10 per cent
F&P Healthcare rallies after reporting strong annual revenue growth.
Stock Takes: Results season to reveal extent of NZ’s downturn
Company results, due this month, are expected to show how stressed the economy is.
Cecilia Robinson: Time to ask a new question about primary care
OPINION: Not every sniffle requires a visit to the doctor.
NZ’s highest-paid CEOs revealed, new record of $8.42m set for largest pay packet
Twenty-five chief executives received at least $2m in remuneration in 2023.
Company results: Comvita slips into the red, Ebos’ profit grows
Comvita blames weak demand in China and Ebos eyeing more purchases.
Bracing for bad news: The stocks to watch this reporting season
Analysts warn this may be the third-worst earnings season ever.
Market close: Shares dip as interest rate cut question weighs on investors
Transport stocks were also under pressure after Maersk said it’s avoiding the Red Sea.
Market close: NZ sharemarket ends roller coaster year
The 'damp end' to the year is not just outside, but in the sharemarket too.
Opinion: Stop losing your marbles over weight-loss wonder drugs
OPINION: Weight-loss drug headlines mask an attractive longer-term picture.
Cecilia Robinson: NZ’s healthcare system needs a major technology upgrade
OPINION: It's essential we upgrade our health system's technological infrastructure.